Whitehawk Therapeutics, Inc.
WHWK- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001422142
No open-market purchases or sales by Whitehawk Therapeutics, Inc. insiders were filed in the last 90 days; 77 institutions reported holding it in 13F filings for Q2 2026, worth $198.0M in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Whitehawk Therapeutics, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 67 | 73 | +6 |
| Shares | 14.3M | 14.7M | +426.2K (+3.0%) |
| Value | $100.8M | $75.3M | −$25.5M (−25.3%) |
New holders (12)
Institutions that held Whitehawk Therapeutics, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| D. E. Shaw & Co., Inc. | 18,450 | $89.3K | 0.00% |
| Virtu Financial LLC | 14,947 | $72.0K | 0.01% |
| Franklin Resources Inc | 12,384 | $59.9K | 0.00% |
| Jane Street Group, LLC | 10,630 | $51.4K | 0.00% |
| STRS Ohio | 1,700 | $8.00K | 0.00% |
| Public Employees Retirement System of Ohio | 1,600 | $8.00K | 0.00% |
| Nisa Investment Advisors, LLC | 1,391 | $6.73K | 0.00% |
| Ronald Blue Trust, Inc. | 705 | $5.00K | 0.00% |
| Operose Advisors LLC | 500 | $2.42K | 0.00% |
| Qube Research & Technologies Ltd | 106 | $513 | 0.00% |
| CWM, LLC | 78 | $0 | 0.00% |
| Avion Wealth | 84 | $0 | 0.00% |
Sold out (6)
Institutions that held Whitehawk Therapeutics, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Affinity Asset Advisors, LLC | 187,675 | $1.28M |
| Bank of Montreal | 22,572 | $187.8K |
| Goldman Sachs Group Inc | 25,215 | $172.5K |
| MetLife Investment Management | 8,693 | $59.5K |
| Metropolitan Life Insurance Co | 812 | $5.55K |
| Russell Investments Group, Ltd. | 266 | $1.82K |